Haleon plc (HLN)
$9.32+0.65%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $41.0B
- Beta
- 0.24
- Div yield
- 2.23%
- P/E (TTM)
- 18.41
- Short % float
- 0.56%
- Days to cover
- 1.0
- SI change
- +13.9%
- 1W
- +5.91%
- 1M
- +1.08%
- vs SPY 1W
- +4.75%
- vs SPY 1M
- -1.91%
Industry peers
FMP comparable companies · ranked by market cap
- GSKSELLGSK plc$94.2BRECOVERYQ 14$47.02-0.09%
- CLBUYColgate-Palmolive Company$69.8BRECOVERYQ 21$87.21+0.19%
- GALD.SWGalderma Group AG$37.9B$162.60
- SDZNYSandoz Group AG$36.7B$84.74
- KVUESELLKenvue Inc.$33.7BBEARQ -4$17.53-0.17%
- CHDBUYChurch & Dwight Co., Inc.$22.9BBEARQ 26$96.75+0.39%
- PRGOBUYPerrigo Company plc$2.0BRECOVERYQ 4$14.55+3.86%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on HLN?
- LOPJLB’s latest quantitative signal on Haleon plc (HLN) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is HLN in?
- Haleon plc (HLN) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Haleon plc (HLN) do?
- Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therape…